Imricor Medical Systems Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Imricor Medical Systems stock has a consensus rating of "Strong Buy" and an average price target of $3.15. The average 1-year stock price forecast is 81.03% higher than the current stock price, while the lowest is $2.27 (+30.46%) and the highest is $3.63 (+108.62%).

Price Target: $3.15 (+81.03%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.27	$3.15	$3.36	$3.63
Change	+30.46%	+81.03%	+93.10%	+108.62%

Analyst Ratings

The average analyst rating for Imricor Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tristan Maher Jarden No rating	Jarden	Buy Maintains $3.30	Buy	Maintains	$3.30	+89.66%	May 20, 2026
Madeleine Williams Canaccord Genuity	Canaccord Genuity	Buy Reiterates $2.33 → $2.28	Buy	Reiterates	$2.33 → $2.28	+31.03%	May 19, 2026
Dennis Hulme Taylor Collison	Taylor Collison	Buy Maintains $3.45	Buy	Maintains	$3.45	+98.28%	May 15, 2026
Scott Power Morgans	Morgans	Buy Maintains $2.71 → $2.63	Buy	Maintains	$2.71 → $2.63	+51.15%	Apr 29, 2026

Financial Forecast

Revenue This Year

3.43M

from 292.31K

1,073.42%

from 292.31K

Revenue Next Year

11.04M

from 3.43M

221.72%

from 3.43M

EPS This Year

-0.07

from -0.07

EPS Next Year

-0.07

from -0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	696.27K	816.01K	615.57K	959.42K	292.31K	3.43M
Revenue Growth	-0.84%	17.20%	-24.56%	55.86%	-69.53%	1,073.42%
Gross Profit	-1.90M	-1.53M	-1.12M	-924.12K	-2.03M	274.40K
Gross Margin	-272.30%	-187.10%	-181.27%	-96.32%	-695.68%	8.00%
Operating Income	-20.26M	-17.26M	-16.86M	-16.30M	-22.79M	-24.34M
Net Income	-19.73M	-17.36M	-22.63M	-29.69M	-25.32M	-30.78M
EPS	-	-	-	-	-0.07	-0.07
Free Cash Flow	-11.34M	-10.60M	-6.08M	-10.41M	-9.17M	-23.20M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	4.5M
Avg	3.4M
Low	2.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	1,429.2%
Avg	1,073.4%
Low	567.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.07
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-